Showing results (121-130 of 185) with videos related to
Sort By:
Pageof 19
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 5, 2008
Metal-ion-dependent biological properties of a chelator-derived somatostatin analogue for tumour targetingAxel Heppeler, João P André, Ingeborg Buschmann, et al.Journal of Medicinal Chemistry|April 16, 2008
Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinityJudit Erchegyi, Christy Rani R Grace, Manoj Samant, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 23, 2014
N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imagingEleni Gourni, Rosalba Mansi, Mazen Jamous, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 15, 2011
Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumorsKeelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclidesRosalba Mansi, Xuejuan Wang, Flavio Forrer, et al.Journal of Medicinal Chemistry|January 24, 2008
Novel sst5-selective somatostatin dicarba-analogues: synthesis and conformation-affinity relationshipsDebora D'Addona, Alfonso Carotenuto, Ettore Novellino, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 30, 2008
Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumoursStephan Good, Martin A Walter, Beatrice Waser, et al.Journal of Medicinal Chemistry|December 5, 2014
Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumorsRosalba Mansi, Keelara Abiraj, Xuejuan Wang, et al.The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Glucagon-like peptide-1 receptor imaging for localization of insulinomasEmanuel Christ, Damian Wild, Flavio Forrer, et al.Cancer Research|January 20, 2011
Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN)Damian Wild, Michael Frischknecht, Hanwen Zhang, et al.Pageof 19